Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 26 Triple Negative Breast Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Adenocarcinoma of Lung 3 Solitary Pulmonary Nodule 1 Rectal Neoplasms 1 Pain, Postoperative 1 Lymphedema 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Breast Cancer Female 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage II Breast Cancer AJCC v8 1 Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Capecitabine 41 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 21 Cetuximab 14 Bevacizumab 14 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Surgical Procedures, Operative 8 Folfox protocol 8 Drug Therapy 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Mastectomy, Segmental × 1 year × Clear all

NCT06249672 2026-05-05

PRESERVE

Insel Gruppe AG, University Hospital Bern

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡